|
Phenylephrine Hydrochloride injection is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.
The drug had total sales of approximately $45 million for the 12-month period ending March 2020, according to IQVIA.
Caplin Steriles, a subsidiary company of Caplin Point Laboratories, has developed and filed 17 ANDAs on its own and with partners, with 9 approvals so far.
The company is also working on a portfolio of 35 simple and complex injectable and ophthalmic products, to be filed over the next 4 years.
Caplin Point Laboratories is a fast-growing pharmaceutical company with a unique business model catering predominantly to emerging markets of Latin America and Africa.
The drug maker reported 27.8% rise in consolidated net profit to Rs 58.56 crore on a 43.5% jump in net sales to Rs 228.21 crore in Q3 December 2019 over Q3 December 2018. The pharmaceutical major is yet to announce its Q4 March 2020 numbers.
|